{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:45:58Z","timestamp":1792532758356,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.immuni.2021.11.002","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T10:43:43Z","timestamp":1638182623000},"page":"82-97.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["CXCL10 chemokine regulates heterogeneity of the CD8+ T\u00a0cell response and viral set point during chronic infection"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3138-3238","authenticated-orcid":false,"given":"Aleksandra J.","family":"Ozga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvyn T.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8730-7336","authenticated-orcid":false,"given":"Mateus E.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Servis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3902-7406","authenticated-orcid":false,"given":"Mauro","family":"Di Pilato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Dehio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9470-7864","authenticated-orcid":false,"given":"Jeffrey","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten R.","family":"Mempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9679-7912","authenticated-orcid":false,"given":"Andrew D.","family":"Luster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2021.11.002_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.160.2.521","article-title":"Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence","volume":"160","author":"Ahmed","year":"1984","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2021.11.002_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","article-title":"TOX reinforces the phenotype and longevity of exhausted T\u00a0cells in chronic viral infection","volume":"571","author":"Alfei","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.11.002_bib3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1101\/gr.241372.118","article-title":"Systems analysis reveals complex biological processes during virus infection fate decisions","volume":"29","author":"Argilaguet","year":"2019","journal-title":"Genome Res."},{"key":"10.1016\/j.immuni.2021.11.002_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T\u00a0cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.11.002_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining \u201cT cell exhaustion\u201d","volume":"19","author":"Blank","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2021.11.002_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in\u00a0vivo","volume":"12","author":"Brooks","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2021.11.002_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ccell.2014.09.007","article-title":"Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T\u00a0cell immunity","volume":"26","author":"Broz","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2021.11.002_bib8","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","article-title":"Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy","volume":"50","author":"Chow","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.11.002_bib9","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1002\/cpim.99","article-title":"Interrogating adaptive immunity using LCMV","volume":"130","author":"Dangi","year":"2020","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.immuni.2021.11.002_bib10","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1016\/j.cell.2021.07.015","article-title":"CXCR6 positions cytotoxic T\u00a0cells to receive critical survival signals in the tumor microenvironment","volume":"184","author":"Di Pilato","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2021.11.002_bib11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41590-021-00878-5","article-title":"Effector and stem-like memory cell fates are imprinted in distinct lymph node niches directed by CXCR3 ligands","volume":"22","author":"Duckworth","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2021.11.002_bib12","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-\u03b3-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T\u00a0cell generation and trafficking","volume":"168","author":"Dufour","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2021.11.002_bib13","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20061462","article-title":"Resolution of a chronic viral infection after interleukin-10 receptor blockade","volume":"203","author":"Ejrnaes","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2021.11.002_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: Redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.immuni.2021.11.002_bib15","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.immuni.2012.08.016","article-title":"CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation","volume":"37","author":"Groom","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.11.002_bib16","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1084\/jem.192.10.1515","article-title":"Requirement of the chemokine receptor CXCR3 for acute allograft rejection","volume":"192","author":"Hancock","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2021.11.002_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature19317","article-title":"Follicular CXCR5-expressing CD8+ T\u00a0cells curtail chronic viral infection","volume":"537","author":"He","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.11.002_bib18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.immuni.2015.02.009","article-title":"CXCR3 chemokine receptor enables local CD8+ T\u00a0cell migration for the destruction of virus-infected cells","volume":"42","author":"Hickman","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.11.002_bib19","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1073\/pnas.1101881108","article-title":"Expression of chemokine receptor CXCR3 on T\u00a0cells affects the balance between effector and memory CD8 T-cell generation","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7652","key":"10.1016\/j.immuni.2021.11.002_bib53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature22079","article-title":"T-cell invigoration to tumor burde ratio associated with anti-PD-1 response","volume":"545","author":"Huang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.11.002_bib20","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1084\/jem.20190173","article-title":"IL-27 promotes the expansion of self-renewing CD8+ T\u00a0cells in persistent viral infection","volume":"216","author":"Huang","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2021.11.002_bib21","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","article-title":"Proliferating transitory T\u00a0cells with an effector-like transcriptional signature emerge from PD-1+ stem-like CD8+ T\u00a0cells during chronic infection","volume":"51","author":"Hudson","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.11.002_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T\u00a0cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.11.002_bib23","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1073\/pnas.1917298117","article-title":"PD-1+ stemlike CD8 T\u00a0cells are resident in lymphoid tissues during persistent LCMV infection","volume":"117","author":"Im","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2021.11.002_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","article-title":"An intra-tumoral niche maintains and differentiates stem-like CD8 T\u00a0cells","volume":"576","author":"Jansen","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.11.002_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1074-7613(00)80200-9","article-title":"IP-10 is critical for effector T\u00a0cell trafficking and host survival in Toxoplasma gondii infection","volume":"12","author":"Khan","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.11.002_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8+ T\u00a0cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.11.002_bib27","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1084\/jem.20102101","article-title":"Chemokine receptor CXCR3 facilitates CD8+ T\u00a0cell differentiation into short-lived effector cells leading to memory degeneration","volume":"208","author":"Kurachi","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2021.11.002_bib28","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41590-019-0480-4","article-title":"PTPN2 regulates the generation of exhausted CD8+ T\u00a0cell subpopulations and restrains tumor immunity","volume":"20","author":"LaFleur","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2021.11.002_bib29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.immuni.2017.11.021","article-title":"Transcription factor IRF4 promotes CD8+ T\u00a0cell exhaustion and limits the development of memory-like T\u00a0cells during chronic infection","volume":"47","author":"Man","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.11.002_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jviromet.2007.08.025","article-title":"Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in\u00a0vivo","volume":"147","author":"McCausland","year":"2008","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.immuni.2021.11.002_bib31","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.4049\/jimmunol.180.10.6713","article-title":"The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor","volume":"180","author":"Meiser","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2021.11.002_bib32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T\u00a0cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2021.11.002_bib33","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"M\u00fcller","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.immuni.2021.11.002_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2012.10.022","article-title":"Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T\u00a0cell immunity","volume":"38","author":"Norris","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.11.002_bib35","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1229620","article-title":"Progenitor and terminal subsets of CD8+ T\u00a0cells cooperate to contain chronic viral infection","volume":"338","author":"Paley","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.immuni.2021.11.002_bib36","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4049\/jimmunol.169.3.1433","article-title":"The CXC chemokine murine monokine induced by IFN-\u03b3 (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in\u00a0vivo","volume":"169","author":"Park","year":"2002","journal-title":"J.\u00a0Immunol."},{"issue":"6316","key":"10.1016\/j.immuni.2021.11.002_bib52","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limit durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.immuni.2021.11.002_bib37","doi-asserted-by":"crossref","first-page":"e136648","DOI":"10.1172\/jci.insight.136648","article-title":"TCF-1 regulates HIV-specific CD8+ T\u00a0cell expansion capacity","volume":"6","author":"Rutishauser","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.immuni.2021.11.002_bib38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T\u00a0cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2021.11.002_bib39","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.4049\/jimmunol.167.12.7084","article-title":"CXCR3 internalization following T\u00a0cell-endothelial cell contact: Preferential role of IFN-inducible T\u00a0cell \u03b1 chemoattractant (CXCL11)","volume":"167","author":"Sauty","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2021.11.002_bib40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","article-title":"TOX is a critical regulator of tumour-specific T\u00a0cell differentiation","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.11.002_bib41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature04606","article-title":"CD69 acts downstream of interferon-\u03b1\/\u03b2 to inhibit S1P1 and lymphocyte egress from lymphoid organs","volume":"440","author":"Shiow","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2021.11.002_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+ T\u00a0cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.11.002_bib43","doi-asserted-by":"crossref","first-page":"14759","DOI":"10.1073\/pnas.0702229104","article-title":"Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12\/SDF-1 receptor, CXCR7","volume":"104","author":"Sierro","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2021.11.002_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","article-title":"T cell factor 1-expressing memory-like CD8+ T\u00a0cells sustain the immune response to chronic viral infections","volume":"45","author":"Utzschneider","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.11.002_bib45","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41590-020-0760-z","article-title":"Early precursor T\u00a0cells establish and propagate T\u00a0cell exhaustion in chronic infection","volume":"21","author":"Utzschneider","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2021.11.002_bib46","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2021.11.002_bib47","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T\u00a0cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2021.11.002_bib48","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T\u00a0cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2021.11.002_bib49","doi-asserted-by":"crossref","first-page":"eaai8593","DOI":"10.1126\/sciimmunol.aai8593","article-title":"The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T\u00a0cell stemness","volume":"1","author":"Wu","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2021.11.002_bib50","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T\u00a0cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2021.11.002_bib51","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","article-title":"CD4+ T\u00a0cell help is required for the formation of a cytolytic CD8+ T\u00a0cell subset that protects against chronic infection and cancer","volume":"51","author":"Zander","year":"2019","journal-title":"Immunity"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761321004933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761321004933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:15:29Z","timestamp":1761034529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761321004933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1074761321004933"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2021.11.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741245247.793591400","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCL10 chemokine regulates heterogeneity of the CD8+ T\u00a0cell response and viral set point during chronic infection","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2021.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}